Immunic, Inc. (IMUX)
NASDAQ: IMUX · IEX Real-Time Price · USD
1.450
+0.060 (4.32%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Immunic Market Cap
Immunic has a market cap or net worth of $130.61 million as of July 26, 2024. Its market cap has increased by 13.97% in one year.
Market Cap
130.61M
Enterprise Value
33.74M
1-Year Change
13.97%
Ranking
Category
Stock Price
$1.45
Market Cap Chart
Since April 17, 2014, Immunic's market cap has decreased from $253.40M to $130.61M, a decrease of -48.46%. That is a compound annual growth rate of -6.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 125.20M | 84.93% |
| Dec 29, 2023 | 67.70M | 23.09% |
| Dec 30, 2022 | 55.00M | -78.11% |
| Dec 31, 2021 | 251.20M | -20.71% |
| Dec 31, 2020 | 316.80M | 222.94% |
| Dec 31, 2019 | 98.10M | 1,141.77% |
| Dec 31, 2018 | 7.90M | -96.85% |
| Dec 29, 2017 | 251.10M | 80.13% |
| Dec 30, 2016 | 139.40M | -60.23% |
| Dec 31, 2015 | 350.50M | -41.04% |
| Dec 31, 2014 | 594.50M | 134.61% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inventiva | 127.72M |
| BrainsWay | 127.51M |
| Athira Pharma | 127.25M |
| DIH Holdings US | 126.50M |
| Agenus | 125.26M |
| American Well | 124.88M |
| Adicet Bio | 124.08M |
| FibroGen | 122.35M |